Interaction of Tamm-Horsfall protein with bacterial extracts. Crude extracts of uropathic Escherichia coli have been reported to inhibit the binding of human Tamm-Horsfall protein (THP) to homologous and heterologous anti-THP antibody in immunoassays. This phenomenon was believed to be due to immunologic cross reactivity between THP and the bacterial antigens for the same antibody. Our attempts to further purify and characterize these "cross reactive" antigens with ion exchange and molecular sieve chromatography were unsuccessful.
strated. These findings suggest that the cross reactivity seen in the immunoassays is caused by the interaction between the bacterial extracts and THP, and is not representative of true immunologic cross reaction for a common antibody.
Tamm-Horsfall protein (THP) is a urinary glycoprotein that has been implicated in the pathogenesis of tubulointerstitial nephritis (TIN) associated with obstructive uropathies and vesicoureteral reflux (VUR) [1, 21 . THP appears to initiate the development of TIN by inducing autoimmunity when it is exposed to the immune system as a consequence of obstruction or VUR [3] [4] [5] . Bacteriuria often complicates urinary tract obstruction and may contribute to the development of TIN by enhancing the autoimmune response to THP. This could occur if the bacteria possessed antigens which cross reacted with THP or through an adjuvant effect of the bacteria.
Fasth et a! [61 have shown that antigens derived from
Escherichia co/i inhibit the binding of THP to specific anti-THP antibody and proposed that these bacterial extracts immunologically cross react with THP. The present studies were undertaken to further define the specifics of the inhibition and to characterize the components of the bacterial extracts which may cross react with THP. In addition we examined the possibility that interactions among the various components in the assay system, other than immunologic cross reactivity, were responsible for the inhibition. Cross reactive components could not be isolated by affinity chromatography with THP antibody immunosorbent, but binding between THP and the bacterial extracts could be shown. Our data suggest that the putative cross reactivity seen in the immunoassay is caused by Received for publication February 13, 1986 and in revised form May 20, 1986 1987 by the International Society of Nephrology 77 interaction between THP and the bacterial extracts rather than between the extracts and THP antibody.
Methods
Tamm-Horsfal/ protein (THP) THP was prepared from pooled human urine, as described by Fletcher, Neuberger and Ratcliffe [71, by repeated precipitation in 0.58 M NaC! followed by extensive dialysis against distilled water. The human (H)THP was stored in the lyophilized state at 4°C. The purity of the preparation was checked by polyacrylamide gel electrophoresis in sodium dodecyl sulfate (SDS). Phosphorylase b, bovine serum albumin, ovalbumin, carbonic anhydrase, soybean trypsin inhibitor and a-lactalbumin were used as molecular weight standards (Pharmacia Fine Chemicals, Piscataway, New Jersey, USA).
Bacterial antigens
Veronal buffer extracts (VE) of E. co/i 014:K7(L):NM (ATCC# 19110) , K/ebsie/la oxytoca and an untypable E. co/i (ECY9) were prepared according to Holmgren et al [81 as modified by Kaijser, Jodal and Hanson [9] . Heat extracts (HE) of these bacteria were also prepared [8] as were antigenic extracts ofAspergi/lusfumigatus [10] and Legione/la pneumophi/ia [11] . Ribonuclease A (Sigma, St. Louis, Missouri, USA) and mannan purified from Candida were used for testing the specificity of the assays. Antisera Rabbit anti-HTHP was raised in New Zealand white rabbits given a single subcutaneous injection of 150 ig HTHP in complete Freund's adjuvant (CFA), followed by three weekly i.v. injections of 50 sg of HTHP in water. The rabbits were bled twice weekly for three weeks beginning two weeks after the final HTHP boost. These sera produced a single precipitin band against HTHP by agar gel diffusion (Ouchterlony). Immunoglobulin fractions were prepared by ammonium sulfate precipitation.
Rabbit antisera to VE of E. co/i 014 were raised by injecting New Zealand white rabbits subcutaneously with 0.8 mg of crude VE in CFA, followed by three weekly subcutaneous injections with 0.4 mg VE in incomplete Freund's adjuvant and a final boost with 25 tg yE. Sera were obtained two and four weeks thereafter. Rabbit antisera against A.fumigatus [10] and L. pneumophila [11] were raised using established methods.
Human sera were obtained from healthy laboratory personnel and from patients with obstructive uropathy or nephrolithiasis.
Radiolabelling
Protein moieties were radiolabelled by the modified chioramme T method [10, 12] . The following reactants were prepared:
1251-HTHP(104 cpmlng) and '251-Staphylococcal protein A(104 cpm/ng).
Antibody determinations
Solid phase radioimmunoassay (SPRIA). Serum anti-HTHP antibody levels were evaluated using a solid phase radioimmunoassay previously developed by us [101. A sample was considered positive if it bound '251-PA at a level more than 2 SD above the mean bound by the normal panel, as described previously [10] .
Enzyme linked immunosorbent assay (ELISA). Serum antibody was also determined by an indirect ELISA procedure.
Microtiter plates were coated with antigen in water (for HTHP), or phosphate buffered saline (PBS) for all other antigens, at 4°C overnight. The wells were aspirated, washed three times with PBS and blocked with 2% BSA-PBS. The plate was aspirated, and antisera diluted in 2% BSA-PBS was added to the antigen coated wells. After overnight incubation at 4°C, the plates were washed three times with PBS. Alkaline phosphatase conjugated anti-human IgG (Sigma) or anti-rabbit IgG (Cappel Laboratories, Malvern, Pennsylvania, USA) diluted 1/1500 in 2% BSA/ PBS was added to each well and incubated for two hours at 37°C. The plate was again washed and p-nitrophenyl phosphate, 1 mg/mi in 0.05 M sodium carbonate, 0.001 M magnesium chloride, 0.02% sodium azide, pH 9.8, was added. The plate was incubated at 37°C to allow color development and then read at 405 nm in an automated ELISA reader (Titertek Multiscan, Flow Labs, McLean, Virginia, USA). A sample was considered positive if its 0D405 was above that of the mean plus two SD of a normal panel, except for anti-YE where an individual serum sample was considered positive if its OD was above the mean plus twice the SE for the total population assayed.
Correlation between individual levels of anti-THP and anti-VE was examined by calculation of the product-moment correlation coefficient (r) according to the formula:
where x is one variable (0D405 for anti-THP) with mean , and y is the other variable (0D405 for anti-YE) with mean 37.
Inhibition studies
Competitive radioimmunoassay (CSPRIA). A competitive radioimmunoassay was employed to detect the level of HTHP or cross reactive antigen in a sample [10, 13] . Briefly, rabbit anti-HTHP IgG (50 sl at 10 tgIml) was adsorbed to polyvinyl microtiter plate wells (Flow Labs). After washing and blocking with BSA, 10 d of '251-THP (10 cpm in 1% BSA-PBS) and 40 d of test antigen in water (non-radioactive HTHP or bacterial extract preparation) were added to the wells. After further incubation (18 hrs at 4°C), the wells were aspirated, washed, dried, cut from the plate, and counted for bound radioactivity. Immunosorbent reagents Sepharose 4B was activated with cyanogen bromide according to the method of Cuatrecasas, Wilcheck and Anfinsen [14] .
HTHP-Sepharose was prepared by a modification of Sela, Wang and Edelman [15] . HTHP and activated Sepharose 4B (2 mg HTHP per ml of sepharose beads) were suspended in 0.1 N sodium bicarbonate, pH 8.3, and gently shaken overnight at 4°C. The preparation was blocked with glycine for two hours at room temperature, washed extensively with alternating solutions of 0.1 N sodium bicarbonate, pH 8.3 and 0.1 M sodium acetate, pH 4, and equilibrated with PBS for storage.
Affinity purified anti-HTHP was prepared by passage of the sera of rabbits immunized to HTHP over a column of HTHPSepharose by a modification of the method of Abbondanza, Licastro and Serafini-Cessi [16] . A column of HTHP-Sepharose was poured, washed with glycine/HC1 buffer (0.05 M glycine/ HC1, 0.05 M NaC1, pH3.0), and then re-equilibrated with PBS. Rabbit sera was diluted with an equal volume of PBS and added to the column. The column was washed with PBS until no protein was detected in the effluent. The affinity-purified anti-HTHP antibody was then eluted from the column with glycine/ HC1, dialyzed, and lyophilized.
Rabbit anti-HTHP coupled Sepharose was prepared by a modification of established procedures [14, 17] . Five ml of cyanogen bromide activated sepharose suspended in 5 ml of 0.1 M sodium bicarbonate, 0.5 M NaC1, pH 8. same way using sera from rabbits which were not immunized.
The effluents and eluents were examined by SPRIA and/or optical density measurement.
Studies of interactions between THP and VE 1.) To glass tubes containing 0.5 ml of HTHP (200 g/ml) and '251HTHp (132,000 cpm) in 4 m phosphate buffer, pH 7.0, was added 0.5 ml of distilled water containing phytohemagglutinin (PHA) or E. coli 014 YE (1000 gig/mi and 200 g/ml).
Mixtures were incubated for four hours at 37°C, one hour at 4°C
and then washed onto 0.45 m filters in a sampling manifold with 2 m phosphate buffer. Filters were dried and counted for radioactivity. 2.) To micro-centrifuge tubes (0.5ml size) previously coated with 1% crystalline BSA in PBS was added 125 pJ '251-HTHP (468,000 cpm) and 125 1 of water, PHA or YE. Concentrations and buffer conditions were the same as described in #1 above. The mixtures were incubated for one hour at 37°C, 18 hours at 4°C, and then centrifuged (2000 xg for 45 minutes). Duplicate 50 1.d aliquots of each supernatant were counted for radioactivity.
3.) Broth cultures of E. co/i (014, ECY9, or fecal isolates obtained from healthy control subjects) were prepared by inoculating trypticase soy broth (TSB) with a single agar-grown colony of each, and incubating the TSB for six or 18 hours at 37°C. Cultures were washed and resuspended (2 m potassium phosphate buffer, 31 m sodium chloride, pH 7.4) at 5 X io E.
co/i/mi, as determined by standard absorbance curves (550 nm). '251-HTHP (lOs cpm) was added to aliquots of E. co/i (5 x iø, iO, 108, or io per ml) in BSA-coated glass tubes which were then incubated at 37°C for one hour and then overnight at 4°C. After centrifugation the pelleted bacteria were resuspended, washed twice in 2 m phosphate buffer, resuspended and transferred to clean tubes, centrifuged, and the pellets counted in a gammacounter (Packard, Downers Grove, Illinois, USA).
Bacteria-free controls included PHA (350 Lg/ml), trichloracetic acid (10%), anti-THP and buffer alone. 4 .) To the wells of micro-ELISA plates 100 pA of the following reactants, separated by PBS washes, were added sequentially: HTHP (10 to 32 g/ml in water) or water alone (control) for 18 hours at 4°C; 1% BSA-PBS for two hours (no wash); YE (0.01 to 5.0 mg/mI in PBS) for five hours; rabbit anti-YE serum (1:1000 in 1% BSA-PBS) for 18 hours at 4°C; alkaline phosphatase-conjugated goat anti-rabbit IgG (1:1500 in 1% BSA-PBS) for two hours at 37°C; and p-nitrophenyl phosphate (1 mg/mI in carbonate buffer, pH 9.8) for >one hour at 37°C. Absorbance was measured at 405 nm.
Immunodiffusion
Agar gel diffusion was performed with Ouchterlony plates by established methods.
Po/yacrylamide gel electrophoresis Yeronal extracts were characterized by polyacrylamide slab gel electrophoresis (PAGE) in the presence of SDS [18] . Samples were routinely boiled for five minutes before addition to the gel. Protein-containing subunits were identified by Coomassie blue staining. Results 
PAGE
HTHP ran as a single protein band corresponding to a molecular weight of approximately 80,000. The protein containing constituents of the veronal buffer extract of the bacteria (VE) were also characterized by PAGE. Figure 1 shows an example of the complex pattern of protein-containing subunits found for the VE of E. co/i 014.
Immunodjffusion Single precipitin bands were formed when HTHP (100 ,ag/ml) was tested against the anti-HTHP antisera raised in rabbits. HTHP did not form a precipitin band with any of the anti-YE antisera raised by immunizing rabbits with the veronal buffer extracts. YE formed three or more precipitin bands with the anti-YE antisera. YE did not form precipitin bands when tested against anti-HTHP antibody in whole sera or against the affinity purified anti-HTHP antibody.
Inhibition of THP anti-THP binding by VE
Prior to testing in the inhibition systems the rabbit anti-HTHP antisera were tested in the direct SPRIA and shown to be of high titer, with antibody detectable in dilutions down to 10-6. The ability of fluid phase HTHP to inhibit the binding between rabbit antibody to HTHP and solid phase HTHP, as determined by the competitive ELISA, is shown in Figure 2 . Fifty percent inhibition occurred with 2.5 x l0 mg HTHP per ml (2.2 x 10-10 moles THP/liter) and 95% inhibition with 1 x i0 mg HTHP/ml. We confirmed that crude YE of E. coli 014 was also inhibitory, but considerably less potent than HTHP. In this example, 50% inhibition of HTHP-anti-HTHP binding occurred with VE at 3 mg/ml, and 75% at 10 mg/ml. The heat Unrelated antigens were also tested in this system. Ribonuclease A and A. fumigatus somatic antigen resulted in no inhibition and 10% inhibition respectively in the CSPRIA at a concentration of 10 mg/ml. Concanavalin A, a mitogen which binds to THP, caused 40% inhibition in the competition ELISA at I mg/ml.
Affinity purification of anti-THP A total of 22 mg of affinity purified anti-HTHP antibody was obtained by passing 60 ml of antiserum over a column of HTHP coupled sepharose and eluting with 0.05 M glycine/HC1, pH 2.3. The affinity purified antibody gave a single band on immunodiffusion against HTHP. SPRIA was able to detect anti-HTHP antibody in solutions of the affinity purified protein at concentrations as low as 10 ng/ml.
Affinity chromatography of THP
The affinity purified anti-HTHP was used to prepare an anti-HTHP sepharose immunosorbent column. Affinity chromatography was performed on samples of HTHP of differing concentrations and volumes. The results of three immunoadsorption runs of HTHP are summarized in Table 1 . Seventyeight to 94% of the HTHP was adsorbed from the samples by the column as determined by comparision of optical density of the effluent (corrected for dilution) with that of the pre-column sample. Immunologically active HTHP was quantitatively recovered in the eluent, as determined by SPRIA.
Affinity chromatography of VE Three trials of immunoadsorption of VE were performed: one using a column technique and two a batch technique. Each trial was followed by an immunoadsorption of I-ITHP as a control to ensure that antibodies on the column were not saturated, and that they had a large capacity to adsorb antigen. The results of the affinity chromatography of YE are summarized in Table 2 .
In no case did immunoadsorption of YE result in decreased cross reactivity of the effluent in the SPRIA. The optical density of the effluent was equal to that of the YE prior to its passage over the column, indicating that the anti-THP antibody conjugated to the column did not bind a significant amount of YE protein. Inhibition by HTHP and VE were also detected by CSPRIA in which the anti-HTHP immunoglobulin fraction was immobilized to the solid phase. In the example shown in Figure 3 , 50% inhibition occurred with 1.5 x iO mg HTHP/ml, 1.5 mg YE/mI and 8 mg HE/mI. Although the sensitivity of this assay to detect nanogramlml concentrations of HTHP was marginally less than 0 10 10_6 1o°iO i0 10-2 10_i 100 10 After reacting VE with the column, repeated attempts were made to elute from the column any material which may have bound to it. No protein was detectable in the eluent by spectrophotometry, and no material was recovered from the eluents after lyophilization.
Correlation between anti-VE and anti-THP titers Anti-VE antibody titers were studied during the course of immunization with THP. We compared the direct binding ability of sera from 35 different rabbits (five challenged with crude VE in CFA, six challenged i.v. with endotoxin-free rabbit THP, six challenged i.v. with endotoxin-containing human THP, and 15 normal unchallenged controls) by ELISA. The results showed that all five of the anti-VE sera bound to solid phase VE (absorbance >2.0 at 405 nm for 1:100 serum dilution). However, only two of 12 sera, one each from the endotoxin-free and the endotoxin-containing THP groups, demonstrated binding to YE, as did two of 15 from the normal control group (absorbance >1.0). Normal rabbit sera which had VE antibody prior to immunization with THP did not demonstrate any change in YE antibody titer as they went on to produce high affinity anti-THP antibody after immunization. It should be noted that the observed YE inhibition of THP/anti-THP binding in the CSPRIA assay was unrelated to the concomitant presence of anti-VE in these anti-THP sera, since inhibition by YE was consistently found for sera containing anti-THP and no anti-VE.
Sera were also surveyed for the presence of anti-THP antibody by ELISA and by SPRIA. None of the rabbits immunized with YE developed anti-THP antibodies. A survey of human sera from 12 healthy laboratory personnel and 66 patients with 
Direct interaction of VE and THP
Since we were unable to demonstrate any direct binding o2 VE to anti-THP, the potential of YE to aggregate, precipitate and/or bind to THP itself was studied. Filtration and centrifugation precipitation studies (Methods) showed that THP and YE did not interact to form sufficiently large aggregates to pellet at 2000 g or to be retained on 0.45 jm filters. PHA, a lectin, was able to produce filter retention of 98.3% of a solution of '251-THP Distilled water resulted in filter retention of only 5% of THP. YE resulted in filter retention of 8% of added '251-THP. In the centrifugation procedure 84% of a solution of '251-THP was precipitated by PHA. Addition of VE to the '251-THP did not result in detectable loss of '251-THP from solution after centrifugation.
Binding of HTHP to whole bacteria was however demonstrated. Figure 4 shows the dose response for four isolates of E. co/i, two of which were uropathic strains (E. coli 014 and ECY9). E. coli 014 at 5 x i09 bacteria per ml bound 3462 cpm of '251-THP. PHA was able to precipitate 30,000 cpm of iodinated THP. A 1/100 dilution of rabbit antibody to H-THP precipitated 12,000 cpm of '251-HTHP; a 1/500 dilution precipitated 6,000 cpm. VE binding to THP and unrelated antigens YE was found to bind directly to solid phase THP in a dose related manner in the ELISA (Fig. 5A) . Detectable YE binding to THP coated ELISA plates was observed using solutions of VE in concentrations as low as 10 tg/ml. Furthermore, as the concentration of solid phase THP adsorbed to the plate was increased, the quantity of bound VE increased proportionately. VE also bound to the solid phase, that is to the BSA itself, in the absence of THP. Nevertheless, the binding of VE in the presence of THP was significantly greater at all concentrations studied.
The ability of YE to bind to other materials was also examined using this ELISA technique (Fig. SB) . When a crude extract of A. fumigatus somatic antigen (at 20 jig/ml) was used to coat the plates, higher YE binding was observed than with the THP (32 jig/mI) coated plates. At 0.5 mg/ml YE the 0D405 for aspergillus coated plates was 0.95 and for THP coated plates was 0.61; at 1 mg/mI YE the 0D405 for aspergillus coated plates was 1.3 and for THP 0.97. Lesser amounts of YE were bound by ovalbumin and by mannan, respectively, than by THP.
Again, VE bound to BSA in the absence of THP, whereas VE did not bind to gelatin.
VE inhibition in non-THP systems The possibility that YE might also inhibit immunoassays of antigen-antibody systems other than THP-anti-THP was examined. Since YE bound to A. fumigatus antigen even better than to THP, we tested the effect of YE on a competitive ELISA to measure aspergillus antigen. Figure 6 shows that YE inhibits the interaction of aspergillus antigen and anti-aspergillus antibody more strongly than it inhibits THP-anti-THP binding. YE at a concentration of 0.5 mg/ml caused 50% inhibition of A. If the explanation is consistent with cross reactivity for the same antibody, then VE must be able to interact with anti-HTHP antibody directly by binding to the Fab portion of the antibody. The cross reactive antigens would then be able to be adsorbed onto an immunoadsorption column which contains anti-HTHP antibody. If, however, YE causes inhibition of binding of HTHP to its antibody by interacting with HTHP itself, then antibody bound to an affinity column would not interact with YE.
The affinity chromatography column composed of affinitypurified anti-HTHP antibody did not adsorb any cross reactive activity from solutions of YE. Even after 250 mg of YE was allowed to incubate with the column for a prolonged period, no protein was adsorbed onto the column, nor was any material able to be eluted from the column. Failure to remove cross reactive materials by affinity chromatography suggests that the inhibition does not arise from YE binding to anti-HTHP antibody.
As further evidence that YE and HTHP are not cross-reactive, we were able to demonstrate that immunization with either antigen did not affect antibody titers directed at the other. We A variety of substances which are not antibodies are known to react with THP. Serafini-Cessi [191 has shown that lectins can bind to the carbohydrate moiety of THP. Leucoagglutinin has also been shown to form a precipitin reaction with THP [16] . Concanavalin A binds to THP and not to antibodies to THP. Concanavalin A was shown in this study to be inhibitory in the competition ELISA. Clearly, binding to THP is sufficient to cause inhibition in this immunoassay. Concanavalin A has also been reported to bind to A. fumigatus somatic antigens [20] . This observation as well as our data which shows binding of VE to A.fumigatus and inhibition by YE of the A.fumigatus competition assay, suggests some similarities in the carbohydrate moieties of THP and A. fumigatus. E. co/i contains pili which act as lectins [21, 221 . PAGE analysis shows that YE contains protein bands with similar electrophoretic mobility to these pilar proteins [23, 24] . Pili such as these, acting as lectins, could bind to THP and cause inhibition of binding of THP to anti-THP, but would fail to be adsorbed by the immunosorbent column since they do not bind to anti-THP. Direct binding of THP and E. co/i is also suggested by the finding that E. co/i with type 1 pili are trapped by THP in normal urine [251. This entrapment is decreased by addition of D-mannose. THP contains mannose in its carbohydrate chain, a fact which may be responsible for its ability to bind E. co/i. Also, our results are in agreement with Kuriyama and Silverblatt [26] who suggested, based on their experiments, that THP may bind to E. co/i type 1 pili, thereby interfering with the binding of THP to THP antibody. In addition, they observed impaired phagocytosis of THP coated E. co/i, and suggested that this impairment might permit the development of persistent infection. Thus, the interaction of THP with some E. co/i may impair normal host defense mechanisms. In contrast, this same interaction of THP with type 1 piliated E. co/i may prevent these organisms from adhering to urinary epithelial cells and protect the host from infection. Although the biological significance of the binding of THP to E. co/i has not yet been definitively determined, current observations suggest both a negative and positive effect on the upper and lower urinary tract, respectively.
Although it appears that the veronal extracts of the strains of E. coli tested do not actually cross react with THP for anti-THP antibody, the possibility of other bacterial preparations truly cross reacting with THP or other renal antigens still exists.
However, our results question the validity of using immunoassays as the sole criterion for reporting cross reactivity. Apparent immunologic activity of a preparation in an immunoassay is not synonymous with cross reaction.
